Results 51 to 60 of about 9,026,275 (240)

Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review

open access: yesSaudi Pharmaceutical Journal, 2014
Ulcerative colitis is the chronic relapsing multifactorial gastrointestinal inflammatory bowel disease, which is characterized by bloody or mucus diarrhea, tenesmus, bowel dystension, anemia.
Nidhi   +5 more
doaj   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

open access: yesMolecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim   +7 more
wiley   +1 more source

Current Update of Clinical Therapeutic Strategies for Colon-Targeted Delivery Systems

open access: yesPharmaceutical Sciences and Research
Oral colon-targeted drug delivery systems represent a significant advancement offering both systemic and local therapeutic effects for a range of intestinal diseases, including irritable bowel syndrome, inflammatory bowel disease, colonic bacterial ...
Risa Widiani Batubara   +2 more
doaj   +1 more source

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease

open access: yesDrug Delivery, 2017
Inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis is a chronic autoimmune disease affecting nearly five million people worldwide.
Hongzhi Qiao   +9 more
doaj   +1 more source

Preparation of a colon-specific sustained-release capsule with curcumin-loaded SMEDDS alginate beads

open access: yesRSC Advances, 2017
A colon-specific capsule with alginate beads containing a self-microemulsifying drug delivery system (SMEDDS) was developed and evaluated.
Yuxia Zhang   +5 more
openaire   +2 more sources

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Investigation into drug release from colon-specific azoreductase-activated steroid prodrugs using in-vitro models

open access: yesJournal of Pharmacy and Pharmacology, 2011
Abstract Objectives The aim of this study was to investigate drug release from a double steroid prodrug, OPN501, which incorporates a phenylpropionate linker, and its phenylacetate analogue. The prodrugs, which were designed to deliver prednisolone to the colon for the treatment of inflammatory bowel ...
Juan F Marquez, Ruiz   +4 more
openaire   +2 more sources

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

open access: yesMolecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen   +19 more
wiley   +1 more source

Degradation studies of modified inulin as potential encapsulation material for colon targeting and release of mesalamine

open access: yes, 2022
S.102-108Due to the potential to treat colon specific diseases with reduced side effects, colon targeting has become of high interest over the last decades.
Walz, Michael   +4 more
core   +1 more source

Development of a chitosan based double layer-coated tablet as a platform for colon-specific drug delivery

open access: yesDrug Design, Development and Therapy, 2016
Min Soo Kim,1,* Dong Woo Yeom,1,* Sung Rae Kim,1 Ho Yub Yoon,1 Chang Hyun Kim,1 Ho Yong Son,1 Jin Han Kim,1 Sangkil Lee,2 Young Wook Choi1 1College of Pharmacy, Chung-Ang University, Seoul, 2College of Pharmacy, Keimyung University, Daegu, South Korea *
Kim MS   +8 more
doaj  

Home - About - Disclaimer - Privacy